As of 2026-01-07, the Relative Valuation of SAGE Therapeutics Inc (SAGE) is (117.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.68 USD, the upside of SAGE Therapeutics Inc based on Relative Valuation is -1448.6%.
The range of the Relative Valuation is (104.30) - (114.57) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.3x - 23.9x | 21.6x |
| Forward P/E multiples | 21.7x - 32.7x | 27.2x |
| Fair Price | (104.30) - (114.57) | (117.06) |
| Upside | -1301.6% - -1419.9% | -1448.6% |
| Date | P/E |